Literature DB >> 21586751

Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM.

Sandra Grass1, Klaus-Dieter Preuss, Stephan Thome, Dennis D Weisenburger, Vinetta Witt, Jane Lynch, Florian Zettl, Lorenz Trümper, Natalie Fadle, Evi Regitz, Henry Lynch, Michael Pfreundschuh.   

Abstract

Paratarg-7 (P-7) is a frequent paraprotein target in monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and Waldenström macroglobulinemia. Patients with P-7-specific paraproteins carry a hyperphosphorylated paratarg-7 (pP-7). Because pP-7 carrier state is dominantly inherited, we determined the paraprotein targets in 4 families with familial MGUS/MM. No antigenic target was identified for the paraproteins from 2 members of one family. Paraproteins from affected members of 2 other families targeted P-7, and paraproteins from 4 affected members of a fourth family targeted P-8, which is encoded by the ATG13 gene. P-8 was hyperphosphorylated in the affected family members (pP-8) and pP-8 carrier state is inherited in a dominant fashion. Six additional autoantigenic nonfamilial paraprotein targets were also hyperphosphorylated in the respective patients compared with normal controls. We conclude that paraproteins of affected members with familial MGUS/MM share family-typical hyperphosphorylated antigens and hyperphosphorylation of paraprotein targets might be a general mechanism underlying the pathogenesis of MGUS/MM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586751     DOI: 10.1182/blood-2011-01-331454

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Inherited genetic susceptibility to multiple myeloma.

Authors:  G J Morgan; D C Johnson; N Weinhold; H Goldschmidt; O Landgren; H T Lynch; K Hemminki; R S Houlston
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

2.  Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.

Authors:  Shiny Nair; Andrew R Branagan; Jun Liu; Chandra Sekhar Boddupalli; Pramod K Mistry; Madhav V Dhodapkar
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

Review 3.  Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.

Authors:  Alexandra J Greenberg; S Vincent Rajkumar; Celine M Vachon
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

4.  Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.

Authors:  Klaus-Dieter Preuss; Michael Pfreundschuh; Martin Weigert; Natalie Fadle; Evi Regitz; Boris Kubuschok
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

5.  Inherited predisposition to multiple myeloma.

Authors:  Divya T Koura; Amelia A Langston
Journal:  Ther Adv Hematol       Date:  2013-08

6.  Inheritance in MGUS and MM.

Authors:  Michael Pfreundschuh
Journal:  Oncotarget       Date:  2015-10-20

Review 7.  Germline Risk Contribution to Genomic Instability in Multiple Myeloma.

Authors:  Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari
Journal:  Front Genet       Date:  2019-05-08       Impact factor: 4.599

8.  Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies.

Authors:  Shaji Kumar; Dirk R Larson; Angela Dispenzieri; Terry M Therneau; David L Murray; P Leif Bergsagel; Robert A Kyle; S Vincent Rajkumar
Journal:  Blood Cancer J       Date:  2019-05-17       Impact factor: 11.037

Review 9.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.